AC
PLSE icon

Allstate Corporation’s Pulse Biosciences PLSE Stock Holding History

Allstate Corporation’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$507K Buy
+23,468
New +$433K 0.01% 998

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Allstate Corporation's PLSE Position: Q1 2026 in Review

Allstate Corporation opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 23,468 shares worth $507K. The stake represents 0.01% of the portfolio and ranks #998 among its holdings.

96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Allstate Corporation held 23,468 shares of Pulse Biosciences worth $507K as of Q1 2026.
  • Pulse Biosciences was a new Allstate Corporation position in Q1 2026.
  • Pulse Biosciences made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #998 holding.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.